Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34)

The summary for the Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34): - The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) seeks to develop cost effective and sustainable interventions, that can be adopted in real world settings, for the prevention and control of diabetes and obesity. Research should be based on interventions already proven efficacious in clinical trials to prevent and reverse obesity and type 2 diabetes, to improve care of type 1 and type 2 diabetes and to prevent or delay its complications. The interventions proposed under this solicitation should have the potential to be widely disseminated to clinical practice, individuals and communities at risk.-This FOA invites research applications for planning grants or pilot studies for translational/dissemination research leading to full scale research in diabetes prevention and control as described in the program announcement, PA-02-153-Relevant topics include 1) methods to improve health care delivery to patients with or at risk of diabetes, 2) to enhance diabetes self management, 3) methods to develop strategies to promote healthy lifestyles to reduce the risk of diabetes, 4) methods to promote lifestyle change that will prevent or reverse overweight and obesity, and 5) new cost effective ways to identify people with pre-diabetes and undiagnosed diabetes.-Important considerations are cost effectiveness and sustainability of the intervention(s) proposed and the ability of interventions to be widely disseminated in settings such as representative health care systems, schools, worksites, or other community settings.-Proposals should test cost effective and sustainable strategies that go beyond research settings to achieve 1) control of glycemia and other risk factors for diabetic complications, including hypertension and dyslipidemia 2) alteration in life style to prevent or reverse overweight, obesity, pre-diabetes, or type 2 diabetes in at-risk populations.-Studies submitted to this program should focus on developing preliminary data demonstrating that the proposed approach is feasible and leads to reduced body weight and or improved glycemia. The interventions proposed must have the clear potential to be applied beyond research settings and to be widely implemented in existing settings in the U.S.-Proposals focused on minorities and other high risk populations disproportionately affected by diabetes and obesity are encouraged. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.-This funding opportunity will utilize the R34 mechanism. A companion announcement of identical scientific scope (PA-02-153) utilizes the Translational research project grant (R18) mechanism.-Eligible organizations: For-profit or non-profit organizations ; Public or private institutions, such as universities, colleges, hospitals; and laboratories; Units of State and local governments; Eligible agencies of the Federal government and; Faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization, Foreign Institutions are not eligible.-Eligible Project Directors/Principal Investigators (PDs/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Investigators new to diabetes and obesity research are encouraged to apply. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for NIH support.-Applicants may submit more than one application, provided there is no scientific or budgetary overlap.-Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-06-358
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Apr 13, 2006
Creation Date: Sep 20, 2007
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award: $150,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. -Domestic Institutions -Faith-based or community-based organizations -Indian/Native American Tribal Government (Federally Recognized); -Indian/Native American Tribal Government (Other than Federally Recognized); -Indian/Native American Tribally Designated Organization
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com